Nizatidine , ≥98% , 76963-41-2

Synonym(s):
N-{2-[2-(N,N-Dimethylaminomethyl)-4-thiazolylmethylthio]ethyl}-N′-methyl-2-nitro-1,1-ethenediamine;Nizatidine

CAS NO.：76963-41-2

Empirical Formula: C12H21N5O2S2

Molecular Weight: 331.46

MDL number: MFCD00865660

EINECS: 627-310-4

PRODUCT Properties

• Melting point: 130-1320C
• Boiling point: 478.2±45.0 °C(Predicted)
• Density: 1.249±0.06 g/cm3(Predicted)
• storage temp.: Keep in dark place,Inert atmosphere,Room temperature
• solubility: Sparingly soluble in water, soluble in methanol.
• form: Solid
• pka: 2.1, 6.8(at 25℃)
• color: Off-White to Pale Yellow
• Water Solubility: 21.4g/L(temperature not stated)
• Merck: 14,6660
• CAS DataBase Reference: 76963-41-2(CAS DataBase Reference)

Description and Uses

Nizatidine is the fifth H₂-antagonist introduced to the world market as an antiulcer agent. It is reported to be effective in the treatment of both duodenal and gastric ulcers or the prevention of their recurrences. Given once-daily, nizatidine’s bioavailability is not diminished by the concurrent administration of an antacid.

For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.

Safety

• Symbol(GHS): GHS07
• Signal word: Warning
• Hazard statements: H302
• Precautionary statements: P264-P270-P301+P312-P501
• Hazard Codes: Xn
• Risk Statements: 22
• Safety Statements: 36
• WGK Germany: 3
• RTECS: KM6565000
• HS Code: 29349990
• Hazardous Substances Data: 76963-41-2(Hazardous Substances Data)
• Toxicity: LD50 in mice, rats (mg/kg): 265, >300 i.v.; 1685, 1680 orally (Pioch)